EnteroMedics Inc.
ETRM
ETRM was delisted on the 20th of October, 2017.
46 hedge funds and large institutions have $10.4M invested in EnteroMedics Inc. in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 12 closing their positions.
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
10% less funds holding
Funds holding: 51 → 46 (-5)
17% less capital invested
Capital invested by funds: $12.5M → $10.4M (-$2.14M)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
83% less call options, than puts
Call options by funds: $16K | Put options by funds: $93K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tenor Capital Management
New York
|
+$3.34M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.28M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.81M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$232K |
| 5 |
VAM
Visium Asset Management
New York
|
+$109K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.52M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$743K |
| 3 |
IHM
Iguana Healthcare Management
New York
|
-$404K |
| 4 |
JGC
J. Goldman & Co
New York
|
-$260K |
| 5 |
BCCM
Blue Clay Capital Management
Minneapolis,
Minnesota
|
-$191K |
ETRM Hedge Fund Activity: Q2 2015 in Review
46 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q2 2015, worth a combined $10.4M — down 17% from $12.5M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ETRM and 7 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 10 added.
The largest buyer was Tenor Capital Management, opening a new position worth an estimated $3.34M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.52M.
- 46 institutional investors held EnteroMedics Inc. (ETRM) as of Q2 2015, down from 51 in Q1 2015.
- Funds reported $10.4M of EnteroMedics Inc. stock for Q2 2015, down 17% quarter-over-quarter.
- 7 funds opened new EnteroMedics Inc. positions in Q2 2015 and 12 closed out, a net change of -5 holders.
- The largest EnteroMedics Inc. buyer in Q2 2015 was Tenor Capital Management, an estimated $3.34M added.
- The largest EnteroMedics Inc. seller in Q2 2015 was T. Rowe Price Associates, an estimated $2.52M sold.
Based on aggregated 13F filings for Q2 2015.